Tonix Pharmaceuticals Holding Corp. (TNXP)

NASDAQ

$6.12

$-0.51

(-7.76%)

Previous Close: ⁦$6.64⁩

Market Closed

Tonix Pharmaceuticals Holding Corp. (TNXP) Live Price Chart

Last updated: ⁦2026-10-14 05:16:20⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Tonix Pharmaceuticals Holding Corp. (TNXP) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $6.12, with a market capitalization of $125.20M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.12 to $20.69. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$125.20M
Open	$6.61
Day's High	$13,440,000,000.00
Day's Low	$6.12
Previous Close	$6.64
Volume	1.10M
Average Volume	548.43K
P/E Ratio	--
52-Week High	$20.69
52-Week Low	$6.12
Dividend Yield	--
Earnings Date	--

Tonix Pharmaceuticals Holding Corp. (TNXP) Latest Closing Stock Price

Tonix Pharmaceuticals Holding Corp. (TNXP) last closed at $6.64 as of 2026-10-13 23:59:00, unchanged from the previous close of $6.64.

During the latest regular trading session, TNXP traded between $6.12 and $13,440,000,000.00, with a volume of 1.10M shares. The closing price was near the lower end and near the lower end of its 52-week range.

Tonix Pharmaceuticals Holding Corp. (TNXP) 7-Day Stock Price Change

Over the past seven days, Tonix Pharmaceuticals Holding Corp. (TNXP) moved from $8.91 to $6.12, representing a decline of 31.27% ($2.79).

The stock traded between $6.12 and $9.56 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.17 million shares, up versus the previous seven-day period, indicating higher trading activity.

TNXP 52-Week Price Position

Position in Range: 0.1%

52W Low$6.12

52W High$20.69

TNXP is currently trading at $6.12, placing it 0.1% of the way from its 52-week low of $6.12 to its 52-week high of $20.69. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Tonix Pharmaceuticals Holding Corp. (TNXP)?

Tonix Pharmaceuticals Holding Corp is a fully-integrated biopharmaceutical company commercializing and developing therapies for central nervous system (CNS) disorders, immunology, infectious diseases, and rare diseases. Its portfolio consists of commercial, development and discovery-stage programs, TONMYA, an approved treatment for fibromyalgia, as well as marketed acute migraine products Zembrace SymTouch and Tosymra. The company is conducting clinical trials to evaluate TONMYA for additional indications such as depressive disorder and acute stress disorder. It is also advancing a pipeline of immunology programs, including monoclonal antibody TNX-4800 for Lyme disease prophylaxis and TNX-1500, a third-generation CD40 ligand inhibitor for the prevention of kidney transplant rejection.

Tonix Pharmaceuticals Holding Corp. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	142
Exchange	NASDAQ
Company Website	https://www.tonixpharma.com

How to Buy Tonix Pharmaceuticals Holding Corp. (TNXP) Stock on MEXC

Eligible investors can buy real shares of Tonix Pharmaceuticals Holding Corp. (TNXP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for TNXP and Place Your Order

Open the RealStocks trading page and search for TNXP. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Tonix Pharmaceuticals Holding Corp. (TNXP) stock price today?

Tonix Pharmaceuticals Holding Corp. (TNXP) is currently trading at $ 6.12, down 7.77% ($0.52) from the previous close of $ 6.64. Intraday prices update in real time during regular trading hours.

2.Is TNXP stock going up or down today?

As of 2026-10-13 23:59:00, TNXP is trading at $ 6.12, down 7.77% ($0.52) from its previous close of $ 6.64. The stock has traded between $ 6.12 and $ 13,440,000,000.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is TNXP pre-market price?

As of 2026-10-13 23:59:00, TNXP is trading at $ 6.63 in pre-market trading, down 0.23% ($0.01) from the previous close of $ 6.64. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is TNXP after-hours price?

As of 2026-10-13 23:59:00, TNXP is trading at $ 6.21 in after-hours trading, down 6.55% ($0.43) from the regular-session close of $ 6.64. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is TNXP stock trading now?

TNXP trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does TNXP sit relative to its 52-week high and low?

Over the past 52 weeks, TNXP has traded between a low of $ 6.12 and a high of $ 20.69. At $ 6.12, the stock is positioned 0.1% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Tonix Pharmaceuticals Holding Corp. in?

Tonix Pharmaceuticals Holding Corp. (TNXP) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Tonix Pharmaceuticals Holding Corp.'s market capitalization and where is it listed?

Tonix Pharmaceuticals Holding Corp. is listed on the NASDAQ exchange with a market capitalization of $ 125.20M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is TNXP valued in terms of P/E ratio and EPS?

TNXP trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -9.31. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Tonix Pharmaceuticals Holding Corp. pay a dividend?

Tonix Pharmaceuticals Holding Corp. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.